HLA Typing for Transplant Market
Global HLA Typing for Transplant Market Size, Share & Trends Analysis Report By Type (Molecular Assays, and Non-Molecular Assays) By Product & Services (Reagents, Software, and Instruments) By Application (Diagnostics, and Research) By End-Users (Academic Institutes & Research Centers, Hospitals & Transplant Centers, and others) Forecast, 2021-2027 Update Available - Forecast 2024-2030
The global human leukocyte antigen (HLA) typing for the transplant market is anticipated to grow at a CAGR of around 6.4% during the forecast period. HLA Typing transplant is an efficient method of matching the tissues of the potential donor with the recipient of the respective tissues. HLA typing is an important procedure used in the transplantation of stem cells, kidney, liver, pancreas, heart transplant, and bone marrow. The increasing number of transplantation procedures owing to the rising number of organ failures is the major factor driving the growth of the HLA Typing. According to the Health Resource & Service Administration, US Department of Health and Human Services, in the US, 107,000+ men, women, and children are on the national transplant waiting list as of February 2021, 39,000 transplants were performed in 2020, and 17 people die every day waiting for an organ transplant. Among all the other organs, Kidney transplantation is on the highest in 2020 which is 20,000, and around 90,000 people are on the waiting list.
Moreover, the increasing geriatric population and growing awareness among the population regarding the importance of organ donation are some of the factors propelling the growth of the global HLA Typing. The US accounted for the largest region with the geriatric population. For instance, the Centers for Disease Control and Prevention predicts that 72 million Americans will be aged 65 years old or older by 2030, accounting for approximately 20% of the United States population. These increasing numbers of elderly populations will inevitably lead to increased chances of organ failures, and transplantation of organs such as kidneys and others. However, the high cost of typing devices and stringent reimbursement policies are some factors limiting the growth of the global HLA Typing. Whereas, the improvement in the healthcare sector in emerging economies such as China, rising demand for low-cost DNA sequencing technology, and increasing public-private funding for R&D activities are likely to fuel the market growth shortly.
Impact of COVID-19 on global HLA Typing for Transplant Market
The global market for HLA typing for transplant is hit by the outbreak of the COVID-19 pandemic. Many hospitals and transplant centers have faced disruption in diagnosis procedures and transplantation due to the lack of transplant diagnostic products and a smaller number of transplant donors. Moreover, the halt in R&D activities by pharmaceutical & biotechnology companies due to the decrease in the public-private fund has negatively affected the market.
Segmental Outlook
The HLA typing for transplant market is segmented based on technology, product & services, application, and end-users. Based on technology, the market can be diversified into non-molecular assays and molecular assays. Non-molecular assays can be further segmented into serological assays and mixed lymphocyte culture assays. Moreover, the molecular assays segment can be further segmented into PCR-based molecular assays and sequencing-based molecular assays. The PCR-based molecular assays are further sub-segmented into sequence-specific primer (SSP-PCR), sequence-specific oligonucleotide (SSO-PCR), sequence-based typing (SBT-PCR), and reference strand-based conformation analysis (RSCA-PCR). The sequencing-based molecular assays can be further sub-segmented into Sanger sequencing and next-generation sequencing. Based on product & services, the market is bifurcated into reagents, software, and instruments. Based on applications, the market is segmented into diagnostics and research. Based on end-users, the market is segmented into academic institutes & research centers, hospitals & transplant centers, and donor registries. Among end-users, the hospital segment holds the largest market share in the HLA Typing. This can be attributed to the growing number of hospitals emerging economies due to the rapid investment in healthcare infrastructure.
Global HLA Typing for Transplant Market Share By Technology, 2020 (%)
The Molecular Assay Segment is Projected to Exhibit the Largest Share in HLA typing for transplants market
Among technology, the molecular assay sub-segment held a considerable market share in 2020, and it is projected to exhibit the largest market share in the HLA typing for transplant market during the forecast period. The market for the molecular assay is further analyzed based on PCR-based molecular assays, and sequencing-based molecular assay. Among these, the PCR-based molecular assay dominated the market and it is expected to maintain its dominance in future years. The advantages associated with PCR molecular assay such as real-time sample analysis, the higher degree of accuracy, faster results, among others is the key reason for the large adoption of this molecular assay in various end-users includes hospitals and transplant centres, and academic institutes & research centers.
Regional Outlook
Geographically, the global HLA typing for transplant market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Asia-Pacific is projected to witness the fastest growth in the global HLA typing for transplant market. The major economies contributing to the growth of the region include China, Japan, India, and South Korea. The factors attributing to the growth of the HLA typing for transplant market in the Asia-Pacific region include the increasing geriatric population with a large number of organ failure, advanced healthcare facilities, and rising public-private funding for research activities for molecular diagnosis.
Global HLA Typing for Transplant Market Growth, By Region 2021-2027
North America Holds the Largest Market Share in Global HLA Typing for Transplant Market
Geographically, North America held the largest share in the global HLA typing for transplant market, and it is anticipated to grow at a significant CAGR during the forecast period. The market growth in the region is mainly attributed to the increasing demand for organ transplants and the rising number of organ donors in the region. The US is the region with a large pool of potential organ donors driving the growth of the region. According to Organ Donation Facts and Statistics, every 10 minutes another person is added to the national transplant list, and 95% of Americans are in favor of being a donor. Moreover, the improvement in the healthcare infrastructure, and adoption of transplant technologies such as HLA, and awareness programs are the factors driving the growth of the HLA typing market in North America.
Market Players Outlook
The key players in the HLA typing for transplant market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market include Biofortuna Ltd., Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd., Illumina, Inc., Luminex Corp., Qiagen GmbH, Thermo Fisher Scientific Inc., among others. These market players are adopting several market strategies including product launch and approvals, merger and acquisition, partnership collaboration, business, and capacity expansion and others. For instance, in April 2020, Creative Biolabs has developed a dedicated NGS-based HLA typing services to facilitate their global clients with related research to disease defense, protection from cancers, organ transplant rejections and biomarkers. The company has also extended the coverage of HLA types, including HLA-A, B, C, G, DRB1, DRB3, DRB4, DRB5, DQA1, DQB1, DPA1, DPB1.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global HLA typing for transplant market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global HLA Typing for Transplant Industry
• Recovery Scenario of Global HLA Typing for Transplant Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on key players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global HLA Typing for Transplant Market, Technology
5.1.1. Non-Molecular Assays
5.1.1.1.1. Serological Assays
5.1.1.1.2. Mixed Lymphocyte Culture Assays
5.1.2. Molecular Assays
5.1.2.1. PCR-Based Molecular Assay
5.1.2.1.1. Sequence-Specific Primer (SSP-PCR)
5.1.2.1.2. Sequence-Specific Oligonucleotide (SSO-PCR)
5.1.2.1.3. Sequence-Based Typing (SBT-PCR)
5.1.2.1.4. Others
5.1.3. Sequencing-Based Molecular Assays
5.1.3.1.1. Sanger Sequencing
5.1.3.1.2. Next-Generation Sequencing
5.2. Global HLA Typing for Transplant Market, By Product & Services
5.2.1. Reagents
5.2.2. Software
5.2.3. Instruments
5.3. Global HLA Typing for Transplant Market, By Applications
5.3.1. Diagnostics
5.3.2. Research
5.4. Global HLA Typing for Transplant Market, By End-Users
5.4.1. Academic Institutes & Research Centers
5.4.2. Hospitals&Transplant Centers
5.4.3. Donor Registries
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
6.4.1. Latin America
6.4.2. Middle East& Africa
7. Company Profiles
7.1. Biofortuna Ltd.
7.2. Bio-Rad Laboratories, Inc
7.3. Biotron Healthcare Pvt. Ltd.
7.4. Creative-Biolabs Inc.
7.5. F. Hoffmann-La Roche Ltd.
7.6. FujirebioDiagnostics, Inc.
7.7. Genome Diagnostics B.V.
7.8. HistoGenetics LLC
7.9. Illumina, Inc.
7.10. Immucor Inc.
7.11. Integrated Gulf Biosystems
7.12. Luminex Corp.
7.13. MC Diagnostics Ltd.
7.14. Omixon Inc.
7.15. Pacific Biosciences of California, Inc.
7.16. PROIMMUNE LTD.
7.17. Qiagen GmbH
7.18. TBG Diagnostics Ltd.
7.19. Thermo Fisher Scientific Inc.
7.20. Voden Medical Instruments S.p.a.
1. GLOBAL HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
2. GLOBAL NON-MOLECULAR ASSAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
3. GLOBAL NON-MOLECULAR ASSAYS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
4. GLOBAL MOLECULAR ASSAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
5. GLOBAL MOLECULAR ASSAYS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
6. GLOBAL HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICES, 2020-2027 ($ MILLION)
7. GLOBAL REAGENTS FOR HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
8. GLOBAL SOFTWARE FOR HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
9. GLOBAL INSTRUMENTS FOR HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
10. GLOBAL HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
11. GLOBAL HLA TYPING FOR TRANSPLANT IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
12. GLOBAL HLA TYPING FOR TRANSPLANT IN RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
13. GLOBAL HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
14. GLOBAL HLA TYPING FOR TRANSPLANT IN ACADEMIC INSTITUTES & RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
15. GLOBAL HLA TYPING FOR TRANSPLANT IN HOSPITALS & TRANSPLANT CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
16. GLOBAL HLA TYPING FOR TRANSPLANT IN DONOR REGISTRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
17. NORTH AMERICAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
18. NORTH AMERICAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY,2020-2027 ($ MILLION)
19. NORTH AMERICAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICES, 2020-2027 ($ MILLION)
20. NORTH AMERICAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
21. NORTH AMERICAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
22. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
23. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY,2020-2027 ($ MILLION)
24. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BYPRODUCT & SERVICES, 2020-2027 ($ MILLION)
25. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
26. EUROPEAN HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION
27. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
28. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
29. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BYPRODUCT & SERVICES,2020-2027 ($ MILLION)
30. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
31. ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
32. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
33. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
34. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY PRODUCT & SERVICES,2020-2027 ($ MILLION)
35. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
36. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL HLA TYPING FOR TRANSPLANT MARKET, 2020-2027 (% MILLION)
2. IMPACT OF COVID-19 ON GLOBAL HLA TYPING FOR TRANSPLANT MARKET BY SEGMENT, 2020-2027 (% MILLION)
3. RECOVERY OF GLOBAL HLA TYPING FOR TRANSPLANT MARKET, 2020-2027 (%)
4. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BY TECHNOLOGY,2020 VS 2027 (%)
5. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BY PRODUCT & SERVICES, 2020 VS 2027 (%)
6. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
7. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BY END-USERS, 2020 VS 2027 (%)
8. GLOBAL HLA TYPING FOR TRANSPLANT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
9. GLOBAL NON-MOLECULAR ASSAYS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
10. GLOBAL NON-MOLECULAR ASSAYS MARKET SHARE BY TYPE, 2020-2027 ($ MILLION)
11. GLOBAL MOLECULAR ASSAYS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
12. GLOBAL MOLECULAR ASSAYS MARKET SHARE BY TYPE, 2020-2027 ($ MILLION)
13. GLOBAL REAGENTS FOR HLA TYPING FOR TRANSPLANT MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
14. GLOBAL SOFTWARE FOR HLA TYPING FOR TRANSPLANT MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
15. GLOBAL INSTRUMENTS FOR HLA TYPING FOR TRANSPLANT MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
16. GLOBAL HLA TYPING FOR TRANSPLANT IN DIAGNOSTICS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
17. GLOBAL HLA TYPING FOR TRANSPLANT IN RESEARCH MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
18. GLOBAL HLA TYPING FOR TRANSPLANT IN ACADEMIC INSTITUTES & RESEARCH CENTERS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
19. GLOBAL HLA TYPING FOR TRANSPLANT IN HOSPITALS & TRANSPLANT CENTERS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
20. GLOBAL HLA TYPING FOR TRANSPLANT IN DONOR REGISTRIES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
21. US HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
22. CANADA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
23. UK HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
24. FRANCE HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
25. GERMANY HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
26. ITALY HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
27. SPAIN HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
28. REST OF EUROPE HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
29. INDIA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
30. CHINA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
31. JAPAN HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
32. SOUTH KOREA HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
33. REST OF ASIA-PACIFIC HLA TYPING FOR TRANSPLANT MARKET SIZE, 2020-2027 ($ MILLION)
34. REST OF THE WORLD HLA TYPING FOR TRANSPLANT MARKET SIZE, 2021-2027($ MILLION
